SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is experiencing heightened social sentiment and trading activity as investors react to its recent availability on major exchanges and the deployment of new DeFi infrastructure like the Tokenator no-code launcher. While the community is actively debating the project's potential for a long-term breakout driven by institutional partnerships and RWA utility, many participants remain cautious, closely monitoring ongoing token supply unlocks and price volatility.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining momentum as a critical infrastructure provider in the DeFi space, fueled by its role in bringing institutional-grade data and U.S. government macroeconomic indicators onto the blockchain. The community is focused on the project's real-world utility, its revenue-sharing model through token buybacks, and its growing importance within the Real World Asset sector.

Fox Corp. engages in providing television production and broadcasting services. It also provides news under the brands FOX News Media, FOX Sports, FOX Entertainment and FOX Television Stations, and Tubi Media Group. It operates through the following segments: Cable Network Programming, Television, and Other and Corporate. The Cable Network Programming segment refers to the production and licensing of news and sports content distributed primarily through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies and online multi-channel video programming distributors. The Television segment focuses on the acquisition, marketing, and distribution of broadcast network programming. The Other and Corporate segment relates to the FOX Studio Lot, Credible Labs Inc, corporate overhead costs, and intracompany eliminations. The company was founded by Keith Rupert Murdoch on May 3, 2018, and is headquartered in New York, NY.

Fox Corporation - Ordinary Shares - Class A

Fox Corporation

Fox Corporation is gaining attention as investors navigate its strategic shift toward sports-focused streaming, highlighted by a high-profile sports bundle initiative alongside industry peers. Meanwhile, community discussions are sharply divided, balancing interest in the stock's media and advertising performance with intense debate over the network's shifting political positioning.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Valero Energy (VLO) is experiencing high volatility as investors weigh the impact of shifting geopolitical tensions and potential supply disruptions against the company's refining fundamentals. The stock remains a focal point for the community due to its sensitivity to crack spreads and policy-driven energy transitions, with traders closely monitoring the intersection of oil price volatility and institutional positioning.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is attracting community attention as investors debate its potential as a high-throughput settlement layer, with active discussions focused on navigating extreme volatility, whale accumulation, and anticipation of upcoming infrastructure developments like fiat anchors. While some participants are capitalizing on price dips for long-term accumulation, others express frustration over the asset's recent performance and the persistent, repetitive nature of the social media commentary surrounding the project.

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Incyte Corp.

Incyte Corporation is currently in the spotlight due to high investor anticipation surrounding potential M&A activity and positive data readouts for its oncology portfolio. Community discussions are heavily focused on the company's strong cash position and the strategic alignment of its pipeline assets as potential targets for major industry players looking to bolster their late-stage oncology holdings.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is trending as investors await critical updates following a recent Type C meeting with the FDA, with community sentiment heavily focused on potential accelerated approval for its ALS treatment, CNM-Au8. Discussion is driven by intense speculation regarding upcoming biomarker analysis results and whether the company will secure an NDA filing by the end of the year.

Canton Coin (CC), the network’s native utility token, was designed to reward real network usage over speculation. It aligns the success of the network with the participants who make it work, fairly rewarding app builders and app users, as well as those operating decentralized infrastructure. The result is a fundamentally different model where rewards flow to those creating value through real activity, not only miners or early investors.

Canton

Canton (CC) is trending as community members rally around its growing institutional partnerships and recent exchange listings, fueling bullish sentiment despite broader market volatility. Investors are actively discussing the project's real-world utility in tokenization and its potential for long-term growth as a key infrastructure layer.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

ConocoPhillips (COP) is currently in the spotlight as investors weigh the stock's role as a major energy play against broader volatility in crude prices and shifting geopolitical risks in the Middle East. While community sentiment remains split between those cautious of recent production news and others focused on the company's long-term value and dividend potential, the stock continues to be heavily monitored as a bellwether for the energy sector's resilience.

EOG Resources, Inc. engages in the exploration, development, production and marketing of crude oil and natural gas. It operates through the United States, Trinidad, and Other International geographical segments. The Other International segment includes China and Canada operations. The company was founded in 1985 and is headquartered in Houston, TX.

EOG Resources, Inc.

EOG Resources is attracting significant investor attention as analysts highlight its strong production efficiencies, disciplined capital allocation, and role as a top-tier operator in major basins like the Permian. The community is actively discussing the company's potential to capitalize on long-term energy demand and rising natural gas exposure, with many monitoring its technical levels as it navigates a volatile sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apellis Pharmaceuticals, Inc. $APLS Holdings Cut by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP cut its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 11.9% in the 3rd quarter, according to its most recent Form 13F filing with...

Cantor Fitzgerald Has Lowered Expectations for Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price

Cantor Fitzgerald dropped their target price on shares of Apellis Pharmaceuticals from $35.00 to $31.00 and set an "overweight" rating for the company in a research report on Wednesday...

Bank of Nova Scotia Acquires 861,413 Shares of Apellis Pharmaceuticals, Inc. $APLS

Bank of Nova Scotia raised its holdings in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 144.8% in the third quarter, according to the company in its most recent Form 13F...

Apellis Pharmaceuticals, Inc. $APLS Shares Bought by HighVista Strategies LLC

HighVista Strategies LLC increased its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 68.2% in the third quarter, according to the company in its most recent 13F...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) have received a consensus rating of "Moderate Buy" from the twenty-two ratings firms that are presently covering the firm...

Apellis Pharmaceuticals (NASDAQ:APLS) Coverage Initiated at Roth Mkm

Roth Mkm initiated coverage on Apellis Pharmaceuticals in a research note on Friday. They set a "buy" rating and a $31.00 price objective on the stock...

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Raised to $37.00 at JPMorgan Chase & Co.

JPMorgan Chase & Co. raised their target price on Apellis Pharmaceuticals from $36.00 to $37.00 and gave the stock an "overweight" rating in a research report on Thursday...

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Raised to $20.00 at Mizuho

Mizuho upped their price objective on shares of Apellis Pharmaceuticals from $19.00 to $20.00 and gave the company a "neutral" rating in a report on Thursday...

Assessing Apellis Pharmaceuticals: Insights From 11 Financial Analysts

Apellis Pharmaceuticals Details SYFOVRE, EMPAVELI Growth Plans and FcRn Gene-Editing Push at TD Cowen Conf.

Apellis Pharmaceuticals (NASDAQ:APLS) executives outlined a three-part strategy for the company at TD Cowen's 46th Annual Healthcare Conference, emphasizing a durable and resilient SYFOVRE franchise...

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Current Price	$17.21
Prev Close	$17.97
Open	$17.96
Dividend Yield	0.00%
50-Day Moving Average	$21.38
Beta	1.03
Avg. Volume	2.17M
PE Ratio	139.35

52-Week High	$30.48
52-Week Low	$16.10
Market Capitalization	$2.2B
EPS (Annual)	$0.1724
Price to Book	5.89
Revenue Per Employee	$1.36M

APLS
Apellis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APLS News

APLSApellis Pharmaceuticals Inc